Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes

IMPORTANCE: Evidence on the effectiveness and safety of COVID-19 therapies across a diverse population with varied risk factors is needed to inform clinical practice. OBJECTIVE: To assess the safety of neutralizing monoclonal antibodies (nMAbs) for the treatment of COVID-19 and their association wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambrose, Nalini, Amin, Alpesh, Anderson, Brian, Barrera-Oro, Julio, Bertagnolli, Monica, Campion, Francis, Chow, Daniel, Danan, Risa, D’Arinzo, Lauren, Drews, Ashley, Erlandson, Karl, Fitzgerald, Kristin, Garcia, Melissa, Gaspar, Fraser W., Gong, Carlene, Hanna, George, Jones, Stephen, Lopansri, Bert, Musser, James, O’Horo, John, Piantadosi, Steven, Pritt, Bobbi, Razonable, Raymund R., Roberts, Seth, Sandmeyer, Suzanne, Stein, David, Vahidy, Farhaan, Webb, Brandon, Yttri, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126875/
https://www.ncbi.nlm.nih.gov/pubmed/37093599
http://dx.doi.org/10.1001/jamanetworkopen.2023.9694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126875/
https://www.ncbi.nlm.nih.gov/pubmed/37093599
http://dx.doi.org/10.1001/jamanetworkopen.2023.9694

Ejemplares similares